openPR Logo
Press release

Mucormycosis Market 2021 Will Reflect Significant Growth in Future with Size, Share, Growth, and Key Companies Analysis

07-07-2021 08:05 PM CET | Health & Medicine

Press release from: Fairfield Market Research

Mucormycosis is a rare and potentially fatal fungal disease that has burst into the limelight recently. The infection is caused by a group of fungi known as mucormycetes and has a high fatality rate. As per U.S. Center for Disease Control and Prevention data, the disease targets the brain, sinuses, and lungs, and is particularly problematic for immune-compromised patients afflicted with HIV, cancer, or diabetes. Mucormycosis can even progress to disfigurement of the eyes, nose, or face, permanent blindness, or invasive brain infection, making it imperative to tackle in the earliest stages of detection.

Get PDF Sample Copy of this Report (Including Full TOC, List of Tables & Figures) :
https://www.fairfieldmarketresearch.com/report/mucormycosis-market/

Lethal Combination of COVID-19 and Steroid Abuse Allows Mucormycosis to Run Rampant in India

The second wave of COVID-19 in India has led to an uptick of mucormycosis cases in the subcontinent. It is likely that mucormycosis is affecting patients due to the excess prescription of immunosuppressant and corticosteroid drugs. Diabetics who contract COVID-19 or those receiving concentrated, humidified oxygen for extended durations are at great risk. For e.g. – Sion hospital in Mumbai has reported a four-fold increase in mucormycosis cases in March 2021, compared to the same period last year. In 2021, India alone accounts for approx. half of global mucormycosis cases. A prominent restraint to overcome in the APAC mucormycosis market is an overall lack of market access. In an Indian study, a quarter of patients were discharged from hospitals before any treatment as they could not afford the medical costs or the medical prognosis was incorrect.

Government Encouragement to Anti-infective Drug Industry Allows Europe to Lead Mucormycosis Market

The pervasiveness of diabetes mellitus has slowly risen in Europe and is now approaching double digits. Furthermore, government initiatives to boost the anti-infective drugs industry is projected to benefit the mucormycosis market in the region. The European Confederation of Medical Mycology (ECCM) is spearheading efforts by drafting global guidelines for the diagnosis and management of mucormycosis.

In Order to place the Purchase Query Click Here: sales@fairfieldmarketresearch.com

Coagulopathy Challenges Fail to Prevent Tissue Biopsy Segment Dominating Mucorymycosis Market

The primary diagnostic test in the mucormycosis market is tissue biopsy, challenges in culturing mucor notwithstanding. Different types of rapid laboratory screening tests comprise Calcofluor White Stain and KOH mount. The benefits of tissue biopsy largely outweigh its risks in cases of location inaccessibility or coagulopathy. Other forms of imaging techniques widely deployed in the mucormycosis market include computed tomography (CT) scans and magnetic resonance imaging (MRI). It is essential to treat mucormycosis as early as possible with amphotericin B, isavuconazole, or Posaconazole – either administered intravenously or orally. The gold standard for treating invasive mucormycosis has long been amphotericin B, while surgical debridement is key in mucormycosis management. Additional options in the mucormycosis market consist of statins, deferasirox, caspofungin, hyperbaric oxygen, and aspirin.

Prevalence of Diabetes Globally Makes Rhinocerebral Mucormycosis A Major Burden

The five types of infections to be tackled in the mucormycosis market are rhinocerebral (sinus and brain), pulmonary (lung), gastrointestinal, cutaneous (skin), and disseminated mucormycosis. Rhinocerebral mucormycosis is most common in those who have undergone a kidney transplant or have diabetes. Conversely, pulmonary mucormycosis rears its ugly head in cancer patients, or in those who have successfully undergone stem cell transplants.

Browse Our Latest Reports: https://www.fairfieldmarketresearch.com/shop/

Fairfield Market Research
London, UK
UK +44 (0)20 30025888
USA +1 (844) 3829746 (Toll-free)
Email: mail@fairfieldmarketresearch.com
Follow us on LinkedIn: https://bit.ly/3voYIm9

Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mucormycosis Market 2021 Will Reflect Significant Growth in Future with Size, Share, Growth, and Key Companies Analysis here

News-ID: 2323638 • Views: 254

More Releases from Fairfield Market Research

Double-digit Growth on the Anvil in Asia-Pacific Yacht Charter Market, States Fa …
The global yacht charter market is driven by an upsurge in leisure activities as consumers across demographics discover the pleasure of yachting to exotic locations. Charter yachts are immensely popular as they rival the best that luxury hotels have to offer with the added advantage of complete seclusion as any tourists can travel to a waterbody of their choice. Tourists can visit several locations in a single trip and avoid
Microbial Fuel Cell (MFC) Market Will be Worth US $15.59 Mn by 2025, Registering …
The global microbial fuel cell (MFC) market is expected to cross the growth threshold required for competitors to make lucrative gains. The total worth of the global microbial fuel cell (MFC) market is expected to supplant US $15 Mn by the end of 2025, growing at a stupendous CAGR of 9.8% during the period between 2021 and 2025. The wide spectrum of applications pertaining to microbial fuel cells is the
Global Graphite Market Poised for a Robust 8.5% CAGR for by 2025; Steelmaking, a …
One of the most desirable materials among those active in the next-generation energy sector, graphite represents a rapidly progressing, multi-billion-dollar market at a global level. Majorly fuelled by the advent of renewable energy sources, and innovations in green energy technologies, Fairfield Market Research expects the global graphite market to see a robust growth outlook during 2021 – 2025. A new report by the company forecasts a strong 8.5% CAGR for
Global Toothpaste Tablet Market to Remain Afloat as Green Practices of Personal …
Sale of toothpaste tablets is gaining momentum as a large section of the global population gravitates towards following staunch standards of personal hygiene. The global value of the toothpaste tablet market is estimated to touch US$152.3 Mn by 2026, growing at a robust CAGR of 6.8% during the period between 2021 and 2026. The past decade has witnessed a heavy uptick in advertising budgets of personal care products. This has

All 5 Releases


More Releases for Mucormycosis

Mucormycosis Market | Trends, Challenges, In-Depth Insights, Strategies (2021-20 …
The Global Mucormycosis Market study includes an assessment of the various factors that are driving the market. Analysts at Fairfield Market Research have included a thorough analysis of the market to present a comprehensive research report. The research report highlights drivers, restraints, opportunities, and threats present in the global Mucormycosis market. With a focus on every aspect, the report suggests the right time to invest in its readers. The report
Mucormycosis Market: Emerging Trends and New Growth Opportunities to 2025 | Nova …
Crystal Market Research (CMR) has added new research study titled,” Mucormycosis Market - Global Industry Analysis & Forecast to 2025”. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. The Mucormycosis Market report based on our unique research methodology delivers thorough analytical scrutiny of the Market dispersed across several segments. The report also consists of current size and summary of
Mucormycosis Market 2019 Analysis - Research Covers Top 10 Players as Abbott Lab …
Market Research Future has added a report titled “Mucormycosis Market Research Report- Global Forecast till 2023” to its offering. Market Scenario: Mucormycosis (zygomycosis) is a serious but rare fungal infection caused by a group of molds called mucormycetes. Moreover, inhaling fungal spores from the air can affect the lungs and sinuses, the fungus also invades the skin through wounds such as cut, scrape, burn, or other type of skin trauma. There are
Mucormycosis Market expected to grow at a CAGR of 7.3% by 2023
Market Research Future has added a report titled “Mucormycosis Market Research Report- Global Forecast till 2023” to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe. Market Scenario: Mucormycosis (zygomycosis) is a serious but rare fungal infection caused by a group of molds called mucormycetes. Moreover, inhaling fungal spores from the
Mucormycosis Market Expected Income, Industry Offer, Improvement Stages, and Sce …
Market Research Future has added a report titled “Mucormycosis Market Research Report- Global Forecast till 2023” to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe. Market Scenario: Mucormycosis (zygomycosis) is a serious but rare fungal infection caused by a group of molds called mucormycetes. Moreover, inhaling fungal spores from the
Mucormycosis Market Set to Surge Significantly During 2026
Mucormycosis is a rapidly progressive and life-threatening invasive fungal disease with high morbidity and mortality rates despite treatment. It primarily affects immunocompromised patients such as those with organ and bone marrow transplantation and hematological malignancy and patients with diabetes, cancer, neutropenia, and skin trauma. In rare cases it also affects immunocompetent patients. Mucormycosis is caused by a group of molds called mucormycetes. Inhaling the spores of the molds can affect